Cambridge Consultants Extends Partnership with MedTech Innovator Asia Pacific

SINGAPORE – August 31, 2022 – Cambridge Consultants, part of Capgemini Invent, is collaborating with MedTech Innovator Asia Pacific for the second consecutive year. MedTech Innovator is the medical technology industry’s global showcase and accelerator for innovative medical device, digital health and diagnostic companies. As part of the collaboration, Cambridge Consultants will continue to partner with the organization to provide hands-on professional support to selected MedTech Innovator Asia Pacific startup participants while also continuing to help in financing the program.

MedTech Innovator Asia Pacific offers best-in-class start-ups with opportunities to work with investors, business leaders and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies throughout the region. Twenty start-ups will be selected for the prestigious program in 2022, with up to US$300,000 in cash prizes and awards available.

“We applaud MedTech Innovator Asia Pacific’s leadership in helping local medtech start-ups, each of which stand to make a meaningful difference in the every-day lives of people across our region, and the world,” said Yan Lin Lye, Head of Asia Pacific Medtech at Cambridge Consultants, part of Capgemini Invent. “Our work with last year’s participating companies was extremely rewarding, with Hong Kong-based Opharmic Technology winning the 2021 Cambridge Consultants Design & Development Award. We look forward to sharing our expertise with this year’s companies.”

Cambridge Consultants joins program sponsors Johnson & Johnson Medical Device Companies, Olympus Medical Systems Group, Siemens Healthineers, Align Technology, Nipro Medical, Oliver Healthcare Packaging and Enterprise Singapore. The 2022 program is also supported by APACMed – the Asia Pacific Medical Technology Association

“We are grateful for Cambridge Consultant’s continued participation in our Asia Pacific program,” said Paul Grand, founder and CEO of MedTech Innovator. “It is partners like them that make our program so significant and impactful. As with our 2021 group, we anticipate helping 2022’s participating companies improve the delivery of health care in ways previously unimagined.”

About MedTech Innovator

Headquartered in Los Angeles, MedTech Innovator is the largest accelerator of medical device companies in the world and the premier nonprofit startup accelerator in the medical technology industry.[i] Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early stage and emerging growth medtech companies for mentorship and support. Its wholly owned subsidiary, MedTech Innovator Asia Pacific, is based in Singapore.

For more information about MedTech Innovator and MedTech Innovator Asia Pacific, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter and on LinkedIn. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.

[i] Gibbs, M., Johnson, B., Silva, B. A., & Berube, K. (2020, July 10). Q2 2020 Life Science Accelerators Insights Cipher Bio. Retrieved September 15, 2020, from https://www.cipherbio.com/blog/life-science-accelerators-insights/

MEDIA CONTACT:

Joe Duraes
Pazanga Health Communications
jduraes@pazangahealth.com
(917) 687-6419